Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Current Neuropharmacology|July 6, 2017
KCa3.1 Channel Modulators as Potential Therapeutic Compounds for GlioblastomaBrandon M Brown, Brandon Pressley, Heike WulffF1000Research|February 14, 2019
Recent advances in our understanding of the structure and function of more unusual cation channelsBrandon M Brown, Hai M Nguyen, Heike WulffAnnual Review of Pharmacology and Toxicology|July 25, 2019
Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium ChannelsBrandon M Brown, Heesung Shim, Palle Christophersen, et al.Molecular Pharmacology|August 2, 2017
Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-<i>d</i>]oxazol-2-amine (SKA-121)Brandon M Brown, Heesung Shim, Miao Zhang, et al.Assay and Drug Development Technologies|December 20, 2013
Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activatorsDavid Paul Jenkins, Weifeng Yu, Brandon M Brown, et al.Frontiers in Pharmacology|October 17, 2019
The Trials and Tribulations of Structure Assisted Design of K<sub>Ca</sub> Channel ActivatorsHeesung Shim, Brandon M Brown, Latika Singh, et al.Epilepsia|March 1, 2024
Computer vision for automated seizure detection and classification: A systematic reviewBrandon M Brown, Aidan M H Boyne, Adel M Hassan, et al.Journal of Chemical Information and Modeling|February 28, 2020
When Does the IC<sub>50</sub> Accurately Assess the Blocking Potency of a Drug?Julio Gomis-Tena, Brandon M Brown, Jordi Cano, et al.Molecular Pharmacology|June 25, 2014
New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1Nichole Coleman, Brandon M Brown, Aida Oliván-Viguera, et al.Epilepsia|March 24, 2025
Video-based detection of tonic-clonic seizures using a three-dimensional convolutional neural networkAidan Boyne, Hsiang J Yeh, Anthony K Allam, et al.Pageof 2